Efficacy and Tolerability of Novel A2A Agonist in Treatment of Diabetic Neuropathic Pain

Summary

The purpose of this study is to evaluate the efficacy and tolerability of BVT.115959 in diabetic patients with neuropathic pain who are either not on analgesia or are on stable analgesia in the month prior to entering the study.

Timeline

Start

2007-05

Primary completion

2007-12

Completion

2008-01

Outcome

Missed primary endpoint

release “the analysis of the primary variable was not statistically significant.” sobi.com ↗

Drugs

Indications